Watch the video from the BMJ channel below:
Home »
BMJ
» Offer new treatments only as part of post-market trials until data on meaningful outcomes are available, says Ben Goldacre to BMJ
When it comes to shielding your identification, perhaps the most vital issue to don't forget is without a doubt getting started out. Mo...
No comments:
Post a Comment